Tag: (ASX:CAN)
CSIRO now set to develop new medicinal cannabis products
CSIRO will work hand-in-hand with local manufacturers to develop new medicinal cannabis therapeutics – a move that will also make room in the local...
Cann Group moves to acquire Satipharm with Share Sale Agreement
The acquisition will fast-track the development of medicinal cannabis delivery systems and formulations to be sold over-the-counter across Australia.
Cann Group Limited (ASX:CAN) has signed...
Featured Article
Balancing profit and sustainability in supply chains
Priorities in the supply chain are expanding, moving away from cost as the main driver behind purchasing decisions. Now, sustainability and ethical sourcing are grabbing a portion of the spotlight.
